Spontaneous systemic lupus erythematosus and acelylator phenotype
- PMID: 848361
- DOI: 10.1111/j.0954-6820.1977.tb15686.x
Spontaneous systemic lupus erythematosus and acelylator phenotype
Abstract
Fifteen patients with spontaneous systemic lupus erythematosus (SLE) have been phenotyped by determination of plasma isoniazid (INH) half-life. Seven patients had signs of renal insufficiency. Of the 15 patients, 13 were slow and only 2 rapid acetylators. No correlation was found between the plasma INH half-lives and the renal function. Thus, there is the same marked predominance of slow acetylators in patients with spontaneous SLE as in patients with the drug-induced SLE-like syndrome.
Similar articles
-
Genetically determined variability in acetylation and oxidation. Therapeutic implications.Drugs. 1985 Apr;29(4):342-75. doi: 10.2165/00003495-198529040-00003. Drugs. 1985. PMID: 2859977 Review.
-
Acetylator phenotype and lupus erythematosus.Clin Pharmacokinet. 1981 Mar-Apr;6(2):118-34. doi: 10.2165/00003088-198106020-00003. Clin Pharmacokinet. 1981. PMID: 7011656 Review.
-
Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects.Br J Clin Pharmacol. 1982 Mar;13(3):361-74. doi: 10.1111/j.1365-2125.1982.tb01387.x. Br J Clin Pharmacol. 1982. PMID: 7059436 Free PMC article.
-
Drug acetylation phenotype unrelated to development of spontaneous systemic lupus erythematosus.Arthritis Rheum. 1979 Jul;22(7):777-80. doi: 10.1002/art.1780220714. Arthritis Rheum. 1979. PMID: 454504
-
Acetylator phenotype and metabolic disposition of isoniazid in Japanese patients with systemic lupus erythematosus.Arthritis Rheum. 1981 Oct;24(10):1245-54. doi: 10.1002/art.1780241004. Arthritis Rheum. 1981. PMID: 7306226
Cited by
-
Disease and acetylation polymorphism.Clin Pharmacokinet. 1977 May-Jun;2(3):182-97. doi: 10.2165/00003088-197702030-00003. Clin Pharmacokinet. 1977. PMID: 328206 Review. No abstract available.
-
Genetically determined variability in acetylation and oxidation. Therapeutic implications.Drugs. 1985 Apr;29(4):342-75. doi: 10.2165/00003495-198529040-00003. Drugs. 1985. PMID: 2859977 Review.
-
Acetylator phenotype and lupus erythematosus.Clin Pharmacokinet. 1981 Mar-Apr;6(2):118-34. doi: 10.2165/00003088-198106020-00003. Clin Pharmacokinet. 1981. PMID: 7011656 Review.
-
Drug metabolites in renal failure: pharmacokinetic and clinical implications.Clin Pharmacokinet. 1981 Sep-Oct;6(5):329-45. doi: 10.2165/00003088-198106050-00001. Clin Pharmacokinet. 1981. PMID: 7037261 Review. No abstract available.
-
Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects.Br J Clin Pharmacol. 1982 Mar;13(3):361-74. doi: 10.1111/j.1365-2125.1982.tb01387.x. Br J Clin Pharmacol. 1982. PMID: 7059436 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources